Healthcare Industry News: HSMN NewsFeed
News Release - February 1, 2012
Toshiba’s Aquilion PRIME CT System Receives FDA ClearanceNew Addition to the Aquilion CT Product Family Offers Ultra-Low Dose and Ultra-Fast Workflow
TUSTIN, Calif.--(Healthcare Sales & Marketing Network)-- Toshiba America Medical Systems, Inc. announces the FDA clearance of the Aquilion™ PRIME CT system, the latest addition to the Aquilion CT product line and part of the “ONE Family” of CT scanners. With double-slice technology and coneXact™ reconstruction algorithm, originally designed for Aquilion ONE, the system can generate 160 unique slices per rotation, enhancing MPR and 3D-rendered images. The Aquilion PRIME was designed for healthcare facilities that need to perform a wide variety of advanced clinical examinations and produce high-quality clinical images with reduced radiation exposure.
The Aquilion PRIME features an 80-row, 0.5 mm detector, a 7.5 MHU large-capacity tube, and 0.35-second scanning. This high-speed rotation allows rapid data acquisition and shortens scan times while the fast reconstruction unit further improves throughput, reducing time required for diagnosis. The system also features a 78 cm aperture gantry, the largest currently available in a high-end CT system. The combination of a 660-pound patient-weight-capacity couch with a large gantry bore makes the Aquilion PRIME an ideal system for use in emergency scanning or bariatric patient studies.
To reinforce the principle of As Low As Reasonably Achievable (ALARA) imaging, Adaptive Iterative Dose Reduction (AIDR) and NEMA XR 25 Dose Check Software are standard features on the Aquilion PRIME. AIDR technology is an iterative process that removes noise from the image with reduced radiation dose. Toshiba’s NEMA XR 25 Dose Check Software enhances user awareness of the radiation dose being administered to patients. This software includes Dose Alert and Dose Notification, addressing the two main components of MITA’s CT Dose Check Initiative, as well as Tracking and Digital Imaging and Communications in Medicine (DICOM), to further enhance dose awareness.
“The combination of the 0.35 second gantry rotation speed and the state-of-the-art reconstruction technology allows many examinations to be performed and reconstructed in mere seconds, improving patient care and overall departmental efficiency,” said Joseph Cooper, director, CT Business Unit, Toshiba. “That, along with standard patient safety features AIDR and NEMA XR 25 Dose Check Software, helps clinicians acquire quality images while attempting to minimize radiation dose as much as possible.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems, and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).
Aquilion ONE, Aquilion and coneXact are trademarks of Toshiba Medical Systems Corporation.
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.